NDC 50268-042

ACETAZOLAMIDE EXTENDED-RELEASE

Acetazolamide Extended-release

ACETAZOLAMIDE EXTENDED-RELEASE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Avpak. The primary component is Acetazolamide.

Product ID50268-042_e43f991d-15ba-1e66-e053-2a95a90a9449
NDC50268-042
Product TypeHuman Prescription Drug
Proprietary NameACETAZOLAMIDE EXTENDED-RELEASE
Generic NameAcetazolamide Extended-release
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-07-20
Marketing CategoryANDA /
Application NumberANDA207401
Labeler NameAvPAK
Substance NameACETAZOLAMIDE
Active Ingredient Strength500 mg/1
Pharm ClassesCarbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 50268-042-12

20 BLISTER PACK in 1 BOX (50268-042-12) > 1 CAPSULE in 1 BLISTER PACK (50268-042-11)
Marketing Start Date2022-07-20
NDC Exclude FlagN
Sample Package?N

Drug Details

Medicade Reported Pricing

50268042712 IMATINIB MESYLATE 400 MG TAB

Pricing Unit: EA | Drug Type:

50268042711 IMATINIB MESYLATE 400 MG TAB

Pricing Unit: EA | Drug Type:

50268042612 IMATINIB MESYLATE 100 MG TAB

Pricing Unit: EA | Drug Type:

50268042611 IMATINIB MESYLATE 100 MG TAB

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "ACETAZOLAMIDE EXTENDED-RELEASE" or generic name "Acetazolamide Extended-release"

NDCBrand NameGeneric Name
42571-243ACETAZOLAMIDE EXTENDED-RELEASEAcetazolamide Extended-Release
50090-5608ACETAZOLAMIDE EXTENDED-RELEASEAcetazolamide Extended-Release
50268-042ACETAZOLAMIDE EXTENDED-RELEASEAcetazolamide Extended-Release

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.